Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
Find a Doctor
Find a doctor at The Johns Hopkins Hospital, Johns Hopkins Bayview Medical Center or Johns Hopkins Community Physicians.
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
Develop Immunologic Therapies the Block Neurologic Injury
In order to develop novel immunologic therapies that stop injury to the brain and spinal cord, the first step is to define why the immune system goes awry and what happens when the immune system crosses into the central nervous system. These studies need to be translated from the laboratory to animal models of multiple sclerosis (MS) and transverse myelitis (TM).
Definition of immune derangements and neural injury pathways:
The main goal of these studies is to identify immune factors that directly or indirectly mediate neuronal/axonal damage in the CNS, and investigate in vivo (within an animal system) neural consequences of inflammatory and non-inflammatory demyelination.
Identification of the neural consequences of immune effector cells utilizing a human neuronal, neuronal/glial and neuronal/glial/immune cell co-culture system are other important studies towards understand neural injury pathways.
Animal model development:
A first step to confirm if the model of injury created in vitro (outside an animal system) hold true in vivo is to develop an animal model that is similar to the disease that develops in humans. By understanding what the immune derangements and the triggers are, we can further the development of an animal model. Animal models hold great promise in studying new therapies prior to the development of clinical trials.
Request an Appointment
Adult Neurology: 410-955-9441
Pediatric Neurology: 410-955-4259
Adult Neurosurgery: 410-955-6406
Pediatric Neurosurgery: 410-955-7337
Already a Patient?
Traveling for Care?
Whether you're crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.